|
1
|
Adebonojo SA, Bowser AN, Moritz DM and
Corcoran PC: Impact of revised stage classification of lung cancer
on survival: a military experience. Chest. 115:1507–1513. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Flehinger BJ, Kimmel M and Melamed MR: The
effect of surgical treatment on survival from early lung cancer.
Implications for screening. Chest. 101:1013–1018. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Naruke T, Goya T, Tsuchiya R and Suemasu
K: The importance of surgery to non-small cell carcinoma of lung
with mediastinal lymph node metastasis. Ann Thorac Surg.
46:603–610. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Allen MS, Darling GE, Pechet TT, Mitchell
JD, Herndon JE II, Landreneau RJ, Inculet RI, Jones DR, Meyers BF,
Harpole DH, et al: Morbidity and mortality of major pulmonary
resections in patients with early-stage lung cancer: initial
results of the randomized, prospective ACOSOG Z0030 trial. Ann
Thorac Surg. 81:1013–1019. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Birim O, Kappetein AP, Goorden T, van
Klaveren RJ and Bogers AJ: Proper treatment selection may improve
survival in patients with clinical early-stage nonsmall cell lung
cancer. Ann Thorac Surg. 80:1021–1026. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ginsberg RJ and Rubinstein LV: Randomized
trial of lobectomy versus limited resection for T1 N0 non-small
cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg.
60:615–623. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Armstrong JG and Minsky BD: Radiation
therapy for medically inoperable stage I and II non-small cell lung
cancer. Cancer Treat Rev. 16:247–255. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coy P, Hodson I, Payne DG, Evans WK, Feld
R, MacDonald AS, Osoba D and Pater JL: The effect of dose of
thoracic irradiation on recurrence in patients with limited stage
small cell lung cancer. Initial results of a Canadian Multicenter
Randomized Trial. Int J Radiat Oncol Biol Phys. 14:219–226. 1988.
View Article : Google Scholar
|
|
9
|
Dosoretz DE, Katin MJ, Blitzer PH,
Rubenstein JH, Galmarini DH, Garton GR and Salenius SA: Medically
inoperable lung carcinoma: the role of radiation therapy. Semin
Radiat Oncol. 6:98–104. 1996. View Article : Google Scholar
|
|
10
|
Haffty BG, Goldberg NB, Gerstley J,
Fischer DB and Peschel RE: Results of radical radiation therapy in
clinical stage I, technically operable non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 15:69–73. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaskowitz L, Graham MV, Emami B, Halverson
KJ and Rush C: Radiation therapy alone for stage I non-small cell
lung cancer. Int J Radiat Oncol Biol Phys. 27:517–523. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong FM, Hayman JA, Griffith KA,
Kalemkerian GP, Arenberg D, Lyons S, Turrisi A, Lichter A, Fraass
B, Eisbruch A, et al: Final toxicity results of a radiation-dose
escalation study in patients with non-small-cell lung cancer
(NSCLC): predictors for radiation pneumonitis and fibrosis. Int J
Radiat Oncol Biol Phys. 65:1075–1086. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sibley GS, Jamieson TA, Marks LB, Anscher
MS and Prosnitz LR: Radiotherapy alone for medically inoperable
stage I non-small-cell lung cancer: the Duke experience. Int J
Radiat Oncol Biol Phys. 40:149–154. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wurstbauer K, Weise H, Deutschmann H, Kopp
P, Merz F, Studnicka M, Nairz O and Sedlmayer F: Non-small cell
lung cancer in stages I-IIIB: long-term results of definitive
radiotherapy with doses ≥ 80 Gy in standard fractionation.
Strahlenther Onkol. 186:551–557. 2010.PubMed/NCBI
|
|
15
|
Zhao L, West BT, Hayman JA, Lyons S, Cease
K and Kong FM: High radiation dose may reduce the negative effect
of large gross tumor volume in patients with medically inoperable
early-stage non-small cell lung cancer. Int J Radiat Oncol Biol
Phys. 68:103–110. 2007.PubMed/NCBI
|
|
16
|
Nath SK, Sandhu AP, Kim D, Bharne A,
Nobiensky PD, Lawson JD, Fuster M, Bazhenova L, Song WY and Mundt
AJ: Locoregional and distant failure following image-guided
stereotactic body radiation for early-stage primary lung cancer.
Radiother Oncol. 99:12–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Detterbeck FC, Boffa DJ and Tanoue LT: The
new lung cancer staging system. Chest. 136:260–271. 2009.
View Article : Google Scholar
|
|
18
|
Lammering G, De Ruysscher D, van Baardwijk
A, Baumert BG, Borger J, Lutgens L, van den Ende P, Ollers M and
Lambin P: The use of FDG-PET to target tumors by radiotherapy.
Strahlenther Onkol. 186:471–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Söhn M, Weinmann M and Alber M:
Intensity-modulated radiotherapy optimization in a
quasi-periodically deforming patient model. Int J Radiat Oncol Biol
Phys. 75:906–914. 2009.PubMed/NCBI
|
|
20
|
Alber M, Birkner M, Laub W and Nüsslin F:
Hyperion: an integrated IMRT planning tool. In: Proceedings of the
XIIIth International Conference on the Use of Computers in
Radiation Therapy; Springer; Heidelberg: pp. 46–48. 2000
|
|
21
|
Alber M and Nusslin F: Optimization of
intensity modulated radiotherapy under constraints for static and
dynamic MLC delivery. Phys Med Biol. 46:3229–3239. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaplan EL and Meier P: Nonparametric
estimation from incomplete observations. J Amer Statist Assoc.
53:457–481. 1953. View Article : Google Scholar
|
|
23
|
Wilcoxon F: Individual comparisons by
ranking methods. Biometrics Bulletin. 1:80–88. 1945. View Article : Google Scholar
|
|
24
|
Roeder F, Friedrich J, Timke C, Kappes J,
Huber P, Krempien R, Debus J and Bischof M: Correlation of
patient-related factors and dose-volume histogram parameters with
the onset of radiation pneumonitis in patients with small cell lung
cancer. Strahlenther Onkol. 186:149–156. 2010.PubMed/NCBI
|
|
25
|
Andolino DL, Forquer JA, Henderson MA,
Barriger RB, Shapiro RH, Brabham JG, Johnstone PA, Cardenes HR and
Fakiris AJ: Chest wall toxicity after stereotactic body
radiotherapy for malignant lesions of the lung and liver. Int J
Radiat Oncol Biol Phys. 80:692–697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hurkmans CW, van Lieshout M, Schuring D,
van Heumen MJ, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide
UA and Senan S: Quality assurance of 4D-CT scan techniques in
multicenter phase III trial of surgery versus stereotactic
radiotherapy (radiosurgery or surgery for operable early stage
(stage 1A) non-small-cell lung cancer [ROSEL] study). Int J Radiat
Oncol Biol Phys. 80:918–927. 2011.PubMed/NCBI
|
|
27
|
Grills IS, Mangona VS, Welsh R,
Chmielewski G, McInerney E, Martin S, Wloch J, Ye H and Kestin LL:
Outcomes after stereotactic lung radiotherapy or wedge resection
for stage I non-small-cell lung cancer. J Clin Oncol. 28:928–935.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bradley J, Graham MV, Winter K, Purdy JA,
Komaki R, Roa WH, Ryu JK, Bosch W and Emami B: Toxicity and outcome
results of RTOG 9311: a phase I–II dose-escalation study using
three-dimensional conformal radiotherapy in patients with
inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol
Phys. 61:318–328. 2005.PubMed/NCBI
|
|
29
|
Hof H, Herfarth KK, Münter M, Hoess A,
Motsch J, Wannenmacher M and Debus JJ: Stereotactic single-dose
radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J
Radiat Oncol Biol Phys. 56:335–341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Timmerman R, McGarry R, Yiannoutsos C,
Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C,
Williams M and Fletcher J: Excessive toxicity when treating central
tumors in a phase II study of stereotactic body radiation therapy
for medically inoperable early-stage lung cancer. J Clin Oncol.
24:4833–4839. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang L, Feigenberg S, Chen L, Pasklev K
and Ma CC: Benefit of three-dimensional image-guided stereotactic
localization in the hypofractionated treatment of lung cancer. Int
J Radiat Oncol Biol Phys. 66:738–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wulf J, Haedinger U, Oppitz U, Thiele W,
Mueller G and Flentje M: Stereotactic radiotherapy for primary lung
cancer and pulmonary metastases: a noninvasive treatment approach
in medically inoperable patients. Int J Radiat Oncol Biol Phys.
60:186–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y,
Li P and Chang JY: Promising clinical outcome of stereotactic body
radiation therapy for patients with inoperable Stage I/II
non-small-cell lung cancer. Int J Radiat Oncol Biol Phys.
66:117–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guckenberger M, Wulf J, Mueller G, Krieger
T, Baier K, Gabor M, Richter A, Wilbert J and Flentje M:
Dose-response relationship for image-guided stereotactic body
radiotherapy of pulmonary tumors: relevance of 4D dose calculation.
Int J Radiat Oncol Biol Phys. 74:47–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jelen U and Alber M: A finite size pencil
beam algorithm for IMRT dose optimization: density corrections.
Phys Med Biol. 52:617–633. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sikora M, Muzik J, Söhn M, Weinmann M and
Alber M: Monte Carlo vs. pencil beam based optimization of
stereotactic lung IMRT. Radiat Oncol. 4:642009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oshiro Y, Aruga T, Tsuboi K, Marino K,
Hara R, Sanayama Y and Itami J: Stereotactic body radiotherapy for
lung tumors at the pulmonary hilum. Strahlenther Onkol.
186:274–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Timmerman R, Paulus R, Galvin J, Michalski
J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone
D, et al: Stereotactic body radiation therapy for inoperable early
stage lung cancer. JAMA. 303:1070–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
